Skip to content

Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review

Aryan Sarparast, Kelan Thomas, Benjamin Malcolm, Christopher S. Stauffer

Psychopharmacology March 7, 2022 DOI: 10.1007/s00213-022-06083-y (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review Peer reviewed
Topics MDMA Psilocybin
Keywords Hallucinogen Psychoactive drug Pharmacology
Citations 85
Key findings Psychiatric drugs, particularly serotonergic medications like SSRIs, can alter the effects and safety profile of MDMA and psilocybin, necessitating careful management during psychedelic-assisted therapy.

Abstract

As MDMA and psilocybin continue to move through the FDA drug development process, this systematic review offers a compilation of existing research on psychiatric drug-drug interactions with MDMA or psilocybin.

Explore topics